Maravai LifeSciences Holdings Inc at Barclays Global Healthcare Conference Transcript
I think we're ready to go. Good morning, everybody. I'm Luke Sergott from Barclays. I cover life science tools and diagnostics. It's my pleasure to have Kevin Herde from Maravai. And we're going to pretty much start on the macro here, but then we can get into some of the core business and some of the other drivers.
Questions & Answers
So with that, just give us an update on -- as we go from Ukraine, Russia, limited exposure, obviously, but I've been asking everybody if they're seeing anything from weakness in demand trends or anything else overall spilling over.
Yes. Great. Well, first of all, thanks, Luke, for having us here. It's nice to be out of the office and see all of you in person.
Specifically with regards to that region, yes, very limited exposure, no
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |